Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
Sign Up to like & getrecommendations! Published in 2019 at "Blood Cancer Journal"
DOI: 10.1038/s41408-019-0254-0
Abstract: Gain of chromosome 1q (+1q) is commonly identified in multiple myeloma and has been associated with inferior outcomes. However, the prognostic implication of +1q has not been evaluated in the setting of standard triplet regimens.… read more here.
Keywords: gain chromosome; myeloma; bortezomib dexamethasone; multiple myeloma ... See more keywords
PATH-48. Molecularly defined glioblastoma with combined gain of chromosome 7 and loss of chromosome 10 presenting microscopically as a low-grade, benign, multi nodular vacuolating tumor
Sign Up to like & getrecommendations! Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.1000
Abstract: We report a case of a 38-year-old German male, without co-morbidities or previous hospitalization, who presented with new onset seizures. Cranial MRI revealed three ill-defined lesions with no contrast enhancement on the left frontal lobe,… read more here.
Keywords: grade; gain chromosome; chromosome loss; tumor ... See more keywords